NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.080
-0.010 (-0.92%)
Jan 23, 2025, 12:10 PM EST - Market open
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $24.98 million as of January 23, 2025. Its market cap has increased by 128.45% in one year.
Market Cap
24.98M
Enterprise Value
24.88M
1-Year Change
128.45%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $24.98M, a decrease of -61.34%. That is a compound annual growth rate of -26.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 25.21M | -9.17% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.91B |
| UnitedHealth Group | 478.29B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 349.76B |
| AbbVie | 299.00B |
| Merck & Co. | 242.04B |
| Thermo Fisher Scientific | 219.78B |
| Intuitive Surgical | 217.43B |